Speeches by Craft.

“I welcome the Secretary of State’s work in improving the NHS and turning fortunes around, but as he has said, that is unfortunately not the case in every area of the country, including my own. Mid and South Essex NHS foundation trust, which looks after constituents in my area including at Basildon university hospital, …”

“1. What steps he is taking to improve underperforming hospital trusts.”

“Will the right hon. Gentleman give way on that point?”

“I should like to declare an interest as a member of the all-party parliamentary group for special educational needs and disabilities and as the parent of a child with an EHCP. I congratulate the hon. Member for Farnham and Bordon (Gregory Stafford) on securing the debate. This is a deeply important subject and, like ma…”

“I agree 100%. We could work out the lifetime cost of a parent being out of work to care for their child who should be in education or in a suitable school, or even the cost of a parent having to draw back from working a certain amount of hours or from reaching where they could go in their career because of the stress t…”

“We provide for it by meeting need at the earliest opportunity. It is about addressing it before it reaches crisis point, unlike the situation we are in now. We would not do this for any other condition. We would not say, “There are too many people out there with cancer—we should stop diagnosing cancer.” It would not wo…”

“Is there a gap, therefore, in the evidence base for this, as you are an evidence-led organisation?”

“John, if I could turn now to wraparound care and NICE guidance on that, during our inquiry we have heard about the importance of wraparound care from those with lived experience and from myriad professionals. Do you have any insights you can share about where and the extent to which the standards are being met for qual…”

“That would be helpful. Is there more that regulators could do in this space, and what would be needed from the Government to support that?”

“You do not currently collect data around where the extent of wraparound care is taking place?”

“I am trying to get to the heart of whether you see that guidance being implemented when it comes to the wraparound care side of it. We obviously have data on the use of prescribing, but not necessarily on that holistic side. It sounds like at the moment you do not have data on whether that guidance is being adhered to.”

“What do you think is needed then? Is the regulation fine and sufficient in this space, or is there something different that needs to—”

“In your role in this space, do you have any measures of success regarding whether you are able to clamp down on inappropriate prescribing? Are there more regulations that you are looking to bring forward or where is your—”

“Would you consider including a contraindication for use on GLP‑1s below a minimum BMI? It seems like what you were saying is that could push more people to go towards the black market rather than—”

“What measures have you got in place to address whether or not the actions you are taking are successful?”

“Is there a risk that if the UK online and offline markets are regulated people will then opt to go elsewhere? Does that cause concern for you?”

“Is there a worry that people unable to access medication via UK online or offline routes are then going elsewhere?”

“Even if it is contraindicated for other health ramifications?”

“Are you confident that that data that you are able to collect from this method reflects the accurate situation on the ground?”

“Would it be based on concerns being reported to regulators?”